RotaTeq® Rotavirus Oral Vaccine for Infants 6-32 Weeks - Single-Dose 2mL Tube
USAMP#69400907SKU: 00006404720RotaTeq®
License Required



Product Spotlight
- RotaTeq® is a live, oral pentavalent vaccine designed to prevent rotavirus gastroenteritis, targeting virus types G1, G2, G3, G4, and G9.
- Specifically approved for infants aged between 6 weeks and 32 weeks, RotaTeq helps protect against severe diarrhea and vomiting caused by rotavirus.
- The vaccination schedule includes three oral doses, with the first dose administered between 6 to 12 weeks of age, followed by two more doses at intervals of 4 to 10 weeks.
- Each dose of RotaTeq is provided in a user-friendly, squeezable plastic dosing tube, ensuring ease of administration.